On-Target Side Effects of Targeted Therapeutics of Cancer

The concept of precision medicine is based on the identification of hallmarks of cancer to exploit them as drug targets. The basic idea was that in this way the therapeutic modalities will be more effective and the side effects will be less. Since the majority of these novel modalities are not speci...

Full description

Bibliographic Details
Main Authors: József Tímár, Andrea Uhlyarik
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Pathology and Oncology Research
Subjects:
Online Access:https://www.por-journal.com/articles/10.3389/pore.2022.1610694/full
_version_ 1797221033451716608
author József Tímár
Andrea Uhlyarik
author_facet József Tímár
Andrea Uhlyarik
author_sort József Tímár
collection DOAJ
description The concept of precision medicine is based on the identification of hallmarks of cancer to exploit them as drug targets. The basic idea was that in this way the therapeutic modalities will be more effective and the side effects will be less. Since the majority of these novel modalities are not specific for a cancer-related biological process or a cancer-specific (mutant) target protein, it is not a surprise that we had to learn new type of side effects, because these therapeutics also affect physiological or pathological processes. Even more, in cases of some of these novel therapies we were able to discover new molecular mechanisms of physiological and pathological processes. Identification of the on-target side effects of targeted drugs can help to prevent the development of them or better manage the patients when emerge during cancer therapy.
first_indexed 2024-04-24T12:59:00Z
format Article
id doaj.art-c6add08fa498404cb721cf0ad667cd3a
institution Directory Open Access Journal
issn 1532-2807
language English
last_indexed 2024-04-24T12:59:00Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Pathology and Oncology Research
spelling doaj.art-c6add08fa498404cb721cf0ad667cd3a2024-04-05T16:34:20ZengFrontiers Media S.A.Pathology and Oncology Research1532-28072022-09-012810.3389/pore.2022.16106941610694On-Target Side Effects of Targeted Therapeutics of CancerJózsef Tímár0Andrea Uhlyarik1Departments of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, HungaryInternal Medicine and Oncology, Semmelweis University, Budapest, HungaryThe concept of precision medicine is based on the identification of hallmarks of cancer to exploit them as drug targets. The basic idea was that in this way the therapeutic modalities will be more effective and the side effects will be less. Since the majority of these novel modalities are not specific for a cancer-related biological process or a cancer-specific (mutant) target protein, it is not a surprise that we had to learn new type of side effects, because these therapeutics also affect physiological or pathological processes. Even more, in cases of some of these novel therapies we were able to discover new molecular mechanisms of physiological and pathological processes. Identification of the on-target side effects of targeted drugs can help to prevent the development of them or better manage the patients when emerge during cancer therapy.https://www.por-journal.com/articles/10.3389/pore.2022.1610694/fullimmunotherapytarget therapybone therapyangiogenesis inhibitorside effectpathomechanism
spellingShingle József Tímár
Andrea Uhlyarik
On-Target Side Effects of Targeted Therapeutics of Cancer
Pathology and Oncology Research
immunotherapy
target therapy
bone therapy
angiogenesis inhibitor
side effect
pathomechanism
title On-Target Side Effects of Targeted Therapeutics of Cancer
title_full On-Target Side Effects of Targeted Therapeutics of Cancer
title_fullStr On-Target Side Effects of Targeted Therapeutics of Cancer
title_full_unstemmed On-Target Side Effects of Targeted Therapeutics of Cancer
title_short On-Target Side Effects of Targeted Therapeutics of Cancer
title_sort on target side effects of targeted therapeutics of cancer
topic immunotherapy
target therapy
bone therapy
angiogenesis inhibitor
side effect
pathomechanism
url https://www.por-journal.com/articles/10.3389/pore.2022.1610694/full
work_keys_str_mv AT jozseftimar ontargetsideeffectsoftargetedtherapeuticsofcancer
AT andreauhlyarik ontargetsideeffectsoftargetedtherapeuticsofcancer